Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP370727.RAD2MA4rtlMjOxsXNX9ofiDReYOAul71N9WREjj-PVP3c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP370727.RAD2MA4rtlMjOxsXNX9ofiDReYOAul71N9WREjj-PVP3c130_assertion type Assertion NP370727.RAD2MA4rtlMjOxsXNX9ofiDReYOAul71N9WREjj-PVP3c130_head.
- NP370727.RAD2MA4rtlMjOxsXNX9ofiDReYOAul71N9WREjj-PVP3c130_assertion description "[In recent studies, we demonstrated the ability of lovastatin, an inhibitor of mevalonate synthesis, to induce the Integrated Stress Response as well as inhibiting epidermal growth factor receptor (EGFR) activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370727.RAD2MA4rtlMjOxsXNX9ofiDReYOAul71N9WREjj-PVP3c130_provenance.
- NP370727.RAD2MA4rtlMjOxsXNX9ofiDReYOAul71N9WREjj-PVP3c130_assertion evidence source_evidence_literature NP370727.RAD2MA4rtlMjOxsXNX9ofiDReYOAul71N9WREjj-PVP3c130_provenance.
- NP370727.RAD2MA4rtlMjOxsXNX9ofiDReYOAul71N9WREjj-PVP3c130_assertion SIO_000772 23029387 NP370727.RAD2MA4rtlMjOxsXNX9ofiDReYOAul71N9WREjj-PVP3c130_provenance.
- NP370727.RAD2MA4rtlMjOxsXNX9ofiDReYOAul71N9WREjj-PVP3c130_assertion wasDerivedFrom befree-20150227 NP370727.RAD2MA4rtlMjOxsXNX9ofiDReYOAul71N9WREjj-PVP3c130_provenance.
- NP370727.RAD2MA4rtlMjOxsXNX9ofiDReYOAul71N9WREjj-PVP3c130_assertion wasGeneratedBy ECO_0000203 NP370727.RAD2MA4rtlMjOxsXNX9ofiDReYOAul71N9WREjj-PVP3c130_provenance.